GENE ONLINE|News &
Opinion
Blog

Clinical Trial
COVID-19 Vaccine
Sanofi/GSK Vaccine Delayed Due to Poor Immunogenicity in Older Adults
2020-12-15
Trials & Approvals Rare Disease
Orladeyo’s FDA approval Heralds New Funding for BioCryst
2020-12-13
R&D
Roche Impresses with its Bispecific Antibody Portfolio for Blood Cancer Treatments
2020-12-13
COVID-19 Vaccine
Indonesia Receives 1.2 Million COVID-19 Vaccines from China’s Sinovac
2020-12-13
COVID-19 mRNA Vaccine
FDA Green Lights Very First COVID-19 Vaccine in the US
2020-12-12
COVID-19 Vaccine
Pfizer’s COVID Vaccine Inches Closer to Emergency Approval Following FDA Panel’s Recommendation
2020-12-11
COVID-19 Vaccine
Spotlight: Comprehensive Analysis of Late-Stage Trial Data of AstraZeneca’s COVID-19 Vaccine
2020-12-10
R&D
Novartis’ Chronic Myeloid Leukemia Drug Demonstrates Superior Results to Pfizer’s
2020-12-10
Trials & Approvals
ASH2020: VelosBio’s ROR1 Targeted Therapy Shines in Safety Trial
2020-12-09
Technology
CRISPR Gene-Edited Therapy CTX001 Raises Hopes for Sickle Cell Disease and β-Thalassemia Cures
2020-12-07
Envafolimab, the First Subcutaneously Administered PD-L1 Antibody for HBV Enters Phase IIb Study
2020-12-07
Trials & Approvals AKCEA-APOCIII-LRx
Ionis Initiates Phase 3 Trials for Familial Chylomicronemia Syndrome Treatment
2020-12-06
Trials & Approvals
Kite Presents Yescarta’s Encouraging Long Term ZUMA-1 Trial Results at ASH2020
2020-12-06
Trials & Approvals
ASH2020: Incyte Presents Positive Phase 3 Data for cGVHD Drug, Ruxolitinib
2020-12-06
COVID-19 Vaccine
COVID-19: BioNTech Commences Phase 2 Vaccine Trials in China with Fosun
2020-12-05
1 … 3 4 5 6 7 … 14
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top